CIK 1595855
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 89.86% | 47 |
| Unclassified | 5.99% | 3 |
| Health Care Equipment & Supplies | 2.24% | 2 |
| Chemicals | 1.46% | 1 |
| Health Care Providers & Services | 0.45% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | HROW | HARROW, INC. | Health Care | 13.15% |
| 2 | LQDA | Liquidia Corp | Health Care | 11.70% |
| 3 | ETON | Eton Pharmaceuticals, Inc. | Health Care | 9.30% |
| 4 | SLGL | SOL GEL TECHNOLOGIES | Unclassified | 5.22% |
| 5 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Health Care | 4.65% |
| 6 | APGE | Apogee Therapeutics, Inc. | Health Care | 4.32% |
| 7 | IRON | Disc Medicine, Inc. | Health Care | 3.55% |
| 8 | URGN | UroGen Pharma Ltd. | Health Care | 3.39% |
| 9 | CBIO | CRESCENT BIOPHARMA, INC. | Health Care | 3.18% |
| 10 | STOK | Stoke Therapeutics, Inc. | Health Care | 3.00% |
51/54 names classified · sector 94.0% of weight · industry 94.0% · mkt cap 94.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 8% of book weight classified — the grid is NOT representative of the whole book.
Classified: 7.5% of book weight (6/53 names) · unclassified 92.5%: HROW, LQDA, ETON, SLGL, RYTM, APGE, IRON, URGN, CBIO, STOK +37 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | HROWHARROW INC | 2,832,230 | $100M | 13.2% | TRIM −27% |
| 2 | LQDALIQUIDIA CORPORATION | 2,545,000 | $89M | 11.7% | ADD 5% |
| 3 | ETONETON PHARMACEUTICALS INC | 2,860,000 | $71M | 9.3% | HOLD |
| 4 | SLGLSOL GEL TECHNOLOGIES | 500,000 | $40M | 5.2% | ADD 10% |
| 5 | RYTMRHYTHM PHARMACEUTICALS INC | 123,000 | $35M | 4.7% | TRIM −63% |
| 6 | APGEAPOGEE THERAPEUTICS INC | 390,000 | $33M | 4.3% | HOLD |
| 7 | IRONDISC MEDICINE INC | 421,000 | $27M | 3.5% | ADD 111% |
| 8 | URGNUROGEN PHARMA LTD | 1,430,000 | $26M | 3.4% | ADD 433% |
| 9 | CBIOCRESCENT BIOPHARMA INC. | 1,312,615 | $24M | 3.2% | ADD 11% |
| 10 | STOKSTOKE THERAPEUTICS INC | 700,000 | $23M | 3.0% | HOLD |
| 11 | CATXPERSPECTIVE THERAPEUTICS INC | 4,675,000 | $19M | 2.6% | ADD 295% |
| 12 | RZLTREZOLUTE INC | 6,300,000 | $19M | 2.5% | HOLD |
| 13 | MGTXMEIRAGTX HLDGS PLC | 2,123,259 | $18M | 2.4% | ADD 443% |
| 14 | TGTXTG THERAPEUTICS INC | 535,000 | $18M | 2.3% | HOLD |
| 15 | SNWVSANUWAVE HEALTH INC | 981,267 | $17M | 2.2% | HOLD |
| 16 | EWTXEDGEWISE THERAPEUTICS INC | 500,000 | $16M | 2.1% | HOLD |
| 17 | ACOGALPHA COGNITION INC | 2,561,950 | $14M | 1.9% | ADD 24% |
| 18 | ANNXANNEXON INC | 2,331,761 | $13M | 1.7% | TRIM −10% |
| 19 | ALMSALUMIS INC | 550,000 | $12M | 1.6% | ADD 3% |
| 20 | CDXSCODEXIS INC | 6,785,000 | $11M | 1.5% | HOLD |
| 21 | PTGXPROTAGONIST THERAPEUTICS INC | 100,000 | $11M | 1.4% | TRIM −5% |
| 22 | RVMDREVOLUTION MEDICINES INC | 100,000 | $10M | 1.3% | HOLD |
| 23 | XOMAXOMA ROYALTY CORPORATION | 300,000 | $9M | 1.2% | ADD 3% |
| 24 | QTTBQ32 BIO INC | 1,256,228 | $8M | 1.1% | ADD 489% |
| 25 | MBXMBX BIOSCIENCES INC | 260,000 | $8M | 1.0% | HOLD |
| 26 | RLMDRELMADA THERAPEUTICS INC | 935,000 | $7M | 0.9% | HOLD |
| 27 | CGONCG ONCOLOGY INC | 94,800 | $6M | 0.8% | TRIM −77% |
| 28 | JBIOJADE BIOSCIENCES INC | 427,608 | $6M | 0.8% | HOLD |
| 29 | OCULOCULAR THERAPEUTIX INC | 600,000 | $5M | 0.7% | TRIM −62% |
| 30 | ASSERTIO HOLDINGS INC | 265,707 | $5M | 0.7% | NEW |
| 31 | EDITEDITAS MEDICINE INC | 1,926,997 | $5M | 0.6% | NEW |
| 32 | STROSUTRO BIOPHARMA INC | 190,671 | $5M | 0.6% | HOLD |
| 33 | DERMJOURNEY MED CORP | 960,000 | $5M | 0.6% | HOLD |
| 34 | VYGRVOYAGER THERAPEUTICS INC | 1,150,000 | $4M | 0.6% | TRIM −4% |
| 35 | TRVITREVI THERAPEUTICS INC | 345,100 | $4M | 0.5% | HOLD |
| 36 | TECXTECTONIC THERAPEUTIC INC | 123,000 | $4M | 0.5% | TRIM −43% |
| 37 | CABACABALETTA BIO INC | 1,380,000 | $4M | 0.5% | ADD 53% |
| 38 | BDSXBIODESIX INC | 238,047 | $3M | 0.5% | NEW |
| 39 | RCKTROCKET PHARMACEUTICALS INC | 955,000 | $3M | 0.5% | HOLD |
| 40 | ZNTLZENTALIS PHARMACEUTICALS INC | 1,412,656 | $3M | 0.4% | HOLD |
| 41 | NTLAINTELLIA THERAPEUTICS INC | 245,000 | $3M | 0.4% | NEW |
| 42 | FBIOFORTRESS BIOTECH INC | 1,042,000 | $3M | 0.4% | TRIM −4% |
| 43 | IRDOPUS GENETICS INC | 1,120,000 | $2M | 0.3% | HOLD |
| 44 | RIGLRIGEL PHARMACEUTICALS INC | 70,000 | $2M | 0.2% | HOLD |
| 45 | AVIRATEA PHARMACEUTICALS INC | 322,600 | $2M | 0.2% | ADD 79% |
| 46 | LYELLYELL IMMUNOPHARMA INC | 79,097 | $2M | 0.2% | NEW |
| 47 | ENTAENANTA PHARMACEUTICALS INC | 125,000 | $2M | 0.2% | ADD 67% |
| 48 | NXTCNEXTCURE INC | 141,181 | $2M | 0.2% | NEW |
| 49 | FDMT4D MOLECULAR THERAPEUTICS IN | 112,291 | $1M | 0.1% | NEW |
| 50 | PERSPECTIVE THERAPEUTICS INC | 200,000 | $834,000 | 0.1% | NEW |
| 51 | PLXPROTALIX BIOTHERAPEUTICS INC | 340,000 | $737,800 | 0.1% | TRIM −86% |
| 52 | BBOTBRIDGEBIO ONCOLOGY THERAPEUTIC | 53,282 | $476,874 | 0.1% | NEW |
| 53 | LBRXLB PHARMACEUTICALS INC | 14,506 | $357,718 | 0.0% | NEW |
| 54 | ADGMADAGIO MED HLDGS INC | 18,444 | $21,211 | 0.0% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| HROWHARROW INC | 4.0M | 4.0M | 3.9M | 3.9M | 3.9M | 2.8M | $100M |
| LQDALIQUIDIA CORPORATION | 1.7M | 2.3M | 2.5M | 2.6M | 2.4M | 2.5M | $89M |
| ETONETON PHARMACEUTICALS INC | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M | $71M |
| SLGLSOL GEL TECHNOLOGIES | — | — | — | 205K | 454K | 500K | $40M |
| RYTMRHYTHM PHARMACEUTICALS INC | 500K | 490K | 475K | 462K | 330K | 123K | $35M |
| APGEAPOGEE THERAPEUTICS INC | — | — | — | 363K | 388K | 390K | $33M |
| IRONDISC MEDICINE INC | — | 85K | 186K | 194K | 200K | 421K | $27M |
| URGNUROGEN PHARMA LTD | 220K | — | — | — | 268K | 1.4M | $26M |
| CBIOCRESCENT BIOPHARMA INC. | — | — | — | — | 1.2M | 1.3M | $24M |
| STOKSTOKE THERAPEUTICS INC | 25K | 300K | 562K | 682K | 695K | 700K | $23M |
| CATXPERSPECTIVE THERAPEUTICS INC | — | — | — | — | 1.2M | 4.7M | $19M |
| RZLTREZOLUTE INC | 465K | 465K | 903K | 903K | 6.3M | 6.3M | $19M |
| MGTXMEIRAGTX HLDGS PLC | — | — | — | — | 391K | 2.1M | $18M |
| TGTXTG THERAPEUTICS INC | 2.3M | 535K | 535K | 535K | 535K | 535K | $18M |
| SNWVSANUWAVE HEALTH INC | — | 972K | 980K | 980K | 981K | 981K | $17M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
